Literature DB >> 7532427

Cytotoxic T lymphocytes induced by liposomal antigens: mechanisms of immunological presentation.

C R Alving1, N M Wassef.   

Abstract

It is known that liposomes can deliver encapsulated substances, including drugs and antigens, to lysosomes in macrophages. Because of this it has been assumed that although liposomes might be useful for induction of humoral (class II) immunity, they would not be capable of cytoplasmic delivery of antigen for introduction into the class I pathway leading to induction of cytotoxic T lymphocytes (CTLs). However, experiments conducted by numerous laboratories, including our own, have demonstrated the ability to induce CTLs either in vitro with cultured cells incubated with liposome-associated antigen, or in vivo after immunization of mice or monkeys with liposomes containing associated antigen. Using a monoclonal antibody that recognizes repeating sequences of tetrapeptide epitopes derived from the circumsporozoite protein of Plasmodium falciparum, it has been shown by immunogold electron microscopy that liposomal antigenic epitopes can actually spill from endosomes into the cytoplasm of cultured macrophages. On the basis of this observation, a theoretical intracellular pathway is proposed whereby liposomal antigen is processed by macrophages through a cytoplasmic process that results in delivery of antigenic epitopes to the Golgi apparatus and the endoplasmic reticulum. The liposomal antigenic epitopes would then have the opportunity to associate with class I MHC molecules and undergo vesicular transport to the surface of the cells for presentation and induction of CTLs.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7532427

Source DB:  PubMed          Journal:  AIDS Res Hum Retroviruses        ISSN: 0889-2229            Impact factor:   2.205


  6 in total

1.  Liposomes containing lipid A serve as an adjuvant for induction of antibody and cytotoxic T-cell responses against RTS,S malaria antigen.

Authors:  R L Richards; M Rao; N M Wassef; G M Glenn; S W Rothwell; C R Alving
Journal:  Infect Immun       Date:  1998-06       Impact factor: 3.441

Review 2.  Recent advancements in cytotoxic T lymphocyte generation methods using carbohydrate-coated liposomes.

Authors:  Yuzuru Ikehara; Masahiro Yamanaka; Takashi Yamaguchi
Journal:  J Biomed Biotechnol       Date:  2010-06-17

3.  Synthesis of a Liposomal MUC1 Glycopeptide-Based Immunotherapeutic and Evaluation of the Effect of l-Rhamnose Targeting on Cellular Immune Responses.

Authors:  Partha Karmakar; Kyunghee Lee; Sourav Sarkar; Katherine A Wall; Steven J Sucheck
Journal:  Bioconjug Chem       Date:  2015-12-09       Impact factor: 4.774

Review 4.  Recent developments in intracellular protein delivery.

Authors:  Yumiao Zhang; Joachim Justad Røise; Kunwoo Lee; Jie Li; Niren Murthy
Journal:  Curr Opin Biotechnol       Date:  2018-02-24       Impact factor: 9.740

5.  Induction of effective and antigen-specific antitumour immunity by a liposomal ErbB2/HER2 peptide-based vaccination construct.

Authors:  A Roth; F Rohrbach; R Weth; B Frisch; F Schuber; W S Wels
Journal:  Br J Cancer       Date:  2005-04-25       Impact factor: 7.640

6.  Immunotherapeutic efficacy of liposome-encapsulated refined allergen vaccines against Dermatophagoides pteronyssinus allergy.

Authors:  Urai Chaisri; Anchalee Tungtrongchitr; Nitaya Indrawattana; Panisara Meechan; Watchara Phurttikul; Natt Tasaniyananda; Nawannaporn Saelim; Wanpen Chaicumpa; Nitat Sookrung
Journal:  PLoS One       Date:  2017-11-28       Impact factor: 3.240

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.